Media Resources

Press Kit

Official facts, releases and media resources for coverage of SmartCemic and NorCemic Inc.

2022Founded

PhoenixArizona HQ

7.61%Glucose MARD

PatentUS pending

About NorCemic Inc.Phoenix, Arizona since 2022

Company OverviewNorCemic Inc. is a medical technology company in Phoenix, Arizona, focused on non-invasive health tracking. SmartCemic, our Biomarker Intelligence Platform, is available today as a wellness app on the web and Android.

MissionTo make reliable health tracking available through affordable, pain-free wellness tracking tools designed for accuracy that give individuals better visibility into their own health data.

TechnologyQESA, our non-invasive device, is in development. It is designed to track biomarkers without needles, strips or lancets, with readings that sync to the SmartCemic app and can be shared with a clinician.

Press ReleasesNewest first

April 2026

FDA Breakthrough Device Designation Request Submitted

NorCemic Inc. submitted a Breakthrough Device Designation request to the FDA Center for Devices and Radiological Health under the 21st Century Cures Act.

December 2024

SmartCemic Device Announced

NorCemic Inc. announced its non-invasive device, now in development, designed to track biomarkers such as glucose, ketones and hydration without needles or blood draws.

October 2024

SmartCemic Wellness Platform Launched

NorCemic Inc. launched the SmartCemic wellness platform, giving people one place to track wellness, set goals and follow their trends.

June 2024

US Patent Application Filed for QESA Technology

NorCemic Inc. filed a US patent application for its QESA technology, covering key innovations in non-invasive biomarker detection.

Brand AssetsAvailable on request by email

Logo PackageLogo files in common formats

Brand GuidelinesColors, typography, usage

App ScreenshotsSmartCemic app images

Fact SheetKey facts and milestones

Media InquiriesEmail our press team

Request Assets Email Press